In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the
In a bid to expand its capacity to make certain key radioisotopes for use in nuclear medicine, MDS Nordion plans to invest $20 million to build a cyclotron in Vancouver, BC. The atom smasher, when completed in January 2003, could double the company’s capacity to produce iodine-123 and palladium-103. MDS Nordion currently operates two cyclotrons at the TRIUMF site located on the University of British Columbia campus and a third in Fleurus, Belgium. These facilities supply more than two-thirds of the world’s reactor-produced isotopes.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.